alteplaseprototypethrombolyticdrugThrombolyticDrugsagentsthatdissolveblood clotsHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiesDVTand PEHeparin isgivenprophylacticallyto patients toprevent thesedabigatranThe onlyoral directthrombininhibitorHemorrhagemajor sideeffect ofHeparintherapyPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarinPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryIdarucizumabAntidotefordabigatranHeparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeActionofwarfarinActs in theliver topreventsynthesis ofvitamin KProtamineSulfateAntidoteforheparinThrombolysisDissolutionof bloodclotsClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersRivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XaHomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.VitaminKantidoteforwarfarintranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.warfarinPrototypevitamin KantagonistDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.PlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotalteplaseprototypethrombolyticdrugThrombolyticDrugsagentsthatdissolveblood clotsHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiesDVTand PEHeparin isgivenprophylacticallyto patients toprevent thesedabigatranThe onlyoral directthrombininhibitorHemorrhagemajor sideeffect ofHeparintherapyPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarinPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryIdarucizumabAntidotefordabigatranHeparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeActionofwarfarinActs in theliver topreventsynthesis ofvitamin KProtamineSulfateAntidoteforheparinThrombolysisDissolutionof bloodclotsClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersRivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XaHomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.VitaminKantidoteforwarfarintranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.warfarinPrototypevitamin KantagonistDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.PlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclot

Chapter 9 Drug Therapy for Coagulation Disorders - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. prototype thrombolytic drug
    alteplase
  2. agents that dissolve blood clots
    Thrombolytic Drugs
  3. A potentially life-threatening complication of heparin administration leading to a decrease in platelet count and detectable HIT antibodies
    Heparin induced thrombocytopenia (HIT)
  4. Heparin is given prophylactically to patients to prevent these
    DVT and PE
  5. The only oral direct thrombin inhibitor
    dabigatran
  6. major side effect of Heparin therapy
    Hemorrhage
  7. Laboratory tests used to manage therapeutic range of warfarin
    PTT and INR
  8. Reversal of warfarin overdose with acute major bleeding or in need of emergent surgery
    PCC
  9. Antidote for dabigatran
    Idarucizumab
  10. inhibits the conversion of prothrombin to thrombin and prevents thrombus formation
    Heparin
  11. laboratory test used to see if heparin is within therapeutic range
    aPTT
  12. Acts in the liver to prevent synthesis of vitamin K
    Action of warfarin
  13. Antidote for heparin
    Protamine Sulfate
  14. Dissolution of blood clots
    Thrombolysis
  15. prototype Adenosine diphosphate receptor antagonist that irreversibly blocks the ADP receptor on platelet cell surface.
    Clopidogrel
  16. QSEN Alert: The nurse should hold the dose of warfarin if the INR is above this number and notify the health care provider
    3
  17. Reversal of thrombolytic agent used in cardiac surgery, blood disorders, hepatic cirrhosis, prostatectomy, and neoplastic disorders
    Aminocaproic acid
  18. direct factor Xa inhibitor prototype that inhibits platelet activation and formation of fibrin clotting by inhibition of factor Xa
    Rivaroxaban
  19. Process that maintains the integrity of the vascular compartment.
    Homeostasis
  20. antidote for warfarin
    Vitamin K
  21. Reversal of thrombolytic agent used for short periods in patients with hemophilia to prevent or decrease breeding form tooth extraction or menorrhagia.
    tranexamic acid
  22. Prototype vitamin K antagonist
    warfarin
  23. Heparin is used to treat this life-threatening condition characterized by widespread clotting, which depletes the blood of coagulation factors.
    Disseminated intravascular coagulation (DIC)
  24. An inactive protein present in many body tissues and fluids that is bound to fibrin and becomes a component of a blood clot
    Plasminogen